514 related articles for article (PubMed ID: 25089547)
1. Long-term outcome of inflammatory bowel diseases with cytomegalovirus colitis: effect of antiviral treatment.
Maconi G; Lombardini M; Furfaro F; Bezzio C; Zerbi P; Ardizzone S
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1146-51. PubMed ID: 25089547
[TBL] [Abstract][Full Text] [Related]
2. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of cytomegalovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study.
Kim YS; Kim YH; Kim JS; Jeong SY; Park SJ; Cheon JH; Ye BD; Jung SA; Park YS; Choi CH; Kim KO; Jang BI; Han DS; Yang SK; Kim WH
Gut Liver; 2014 Nov; 8(6):643-7. PubMed ID: 25368753
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.
Pillet S; Pozzetto B; Roblin X
World J Gastroenterol; 2016 Feb; 22(6):2030-45. PubMed ID: 26877608
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis.
Clos-Parals A; Rodríguez-Martínez P; Cañete F; Mañosa M; Ruiz-Cerulla A; José Paúles M; Llaó J; Gordillo J; Fumagalli C; Garcia-Planella E; Ojanguren I; Cabré E; Guardiola J; Domènech E
J Crohns Colitis; 2019 Mar; 13(3):385-388. PubMed ID: 30346606
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status.
Inokuchi T; Kato J; Hiraoka S; Suzuki H; Nakarai A; Hirakawa T; Akita M; Takahashi S; Harada K; Okada H; Yamamoto K
World J Gastroenterol; 2014 Jan; 20(2):509-17. PubMed ID: 24574719
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis.
Roblin X; Pillet S; Oussalah A; Berthelot P; Del Tedesco E; Phelip JM; Chambonnière ML; Garraud O; Peyrin-Biroulet L; Pozzetto B
Am J Gastroenterol; 2011 Nov; 106(11):2001-8. PubMed ID: 21788989
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection.
Maconi G; Colombo E; Zerbi P; Sampietro GM; Fociani P; Bosani M; Cassinotti A; Casini V; Russo A; Ardizzone S; Porta M; Bianchi Porro G
Dig Liver Dis; 2005 Jun; 37(6):418-23. PubMed ID: 15893280
[TBL] [Abstract][Full Text] [Related]
9. Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis.
Okahara K; Nagata N; Shimada T; Joya A; Hayashida T; Gatanaga H; Oka S; Sakurai T; Uemura N; Akiyama J
PLoS One; 2017; 12(9):e0183951. PubMed ID: 28886066
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus colitis in hospitalized inflammatory bowel disease patients in Taiwan: a referral center study.
Weng MT; Tung CC; Lee YS; Leong YL; Shieh MJ; Shun CT; Wang CY; Wong JM; Wei SC
BMC Gastroenterol; 2017 Feb; 17(1):28. PubMed ID: 28193173
[TBL] [Abstract][Full Text] [Related]
11. True cytomegalovirus colitis is a poor prognostic indicator in patients with ulcerative colitis flares: the 10-year experience of an academic referral inflammatory bowel disease center.
Oh SJ; Lee CK; Kim YW; Jeong SJ; Park YM; Oh CH; Kim JW; Kim HJ
Scand J Gastroenterol; 2019 Aug; 54(8):976-983. PubMed ID: 31356759
[No Abstract] [Full Text] [Related]
12. Cytomegalovirus infection and postoperative complications in patients with ulcerative colitis undergoing colectomy.
Olaisen M; Rydning A; Martinsen TC; Nordrum IS; Mjønes P; Fossmark R
Scand J Gastroenterol; 2014 Jul; 49(7):845-52. PubMed ID: 24947587
[TBL] [Abstract][Full Text] [Related]
13. The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease.
Delvincourt M; Lopez A; Pillet S; Bourrier A; Seksik P; Cosnes J; Carrat F; Gozlan J; Beaugerie L; Roblin X; Peyrin-Biroulet L; Sokol H
Aliment Pharmacol Ther; 2014 Apr; 39(7):712-20. PubMed ID: 24506221
[TBL] [Abstract][Full Text] [Related]
14. Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy for cytomegalovirus.
Jones A; McCurdy JD; Loftus EV; Bruining DH; Enders FT; Killian JM; Smyrk TC
Clin Gastroenterol Hepatol; 2015 May; 13(5):949-55. PubMed ID: 25283582
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients.
Matsuoka K; Iwao Y; Mori T; Sakuraba A; Yajima T; Hisamatsu T; Okamoto S; Morohoshi Y; Izumiya M; Ichikawa H; Sato T; Inoue N; Ogata H; Hibi T
Am J Gastroenterol; 2007 Feb; 102(2):331-7. PubMed ID: 17156136
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies.
Yoshino T; Nakase H; Ueno S; Uza N; Inoue S; Mikami S; Matsuura M; Ohmori K; Sakurai T; Nagayama S; Hasegawa S; Sakai Y; Chiba T
Inflamm Bowel Dis; 2007 Dec; 13(12):1516-21. PubMed ID: 17828781
[TBL] [Abstract][Full Text] [Related]
17. Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases.
Lévêque N; Brixi-Benmansour H; Reig T; Renois F; Talmud D; Brodard V; Coste JF; De Champs C; Andréoletti L; Diebold MD
J Med Virol; 2010 Oct; 82(10):1694-700. PubMed ID: 20827767
[TBL] [Abstract][Full Text] [Related]
18. Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.
Kopylov U; Papamichael K; Katsanos K; Waterman M; Bar-Gil Shitrit A; Boysen T; Portela F; Peixoto A; Szilagyi A; Silva M; Maconi G; Har-Noy O; Bossuyt P; Mantzaris G; Barreiro de Acosta M; Chaparro M; Christodoulou DK; Eliakim R; Rahier JF; Magro F; Drobne D; Ferrante M; Sonnenberg E; Siegmund B; Muls V; Thurm T; Yanai H; Dotan I; Raine T; Levin A; Israeli E; Ghalim F; Carbonnel F; Vermeire S; Ben-Horin S; Roblin X
Inflamm Bowel Dis; 2017 Sep; 23(9):1605-1613. PubMed ID: 28590343
[TBL] [Abstract][Full Text] [Related]
19. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
[TBL] [Abstract][Full Text] [Related]
20. Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis.
Pillet S; Jarlot C; Courault M; Del Tedesco E; Chardon R; Saint-Sardos P; Presles E; Phelip JM; Berthelot P; Pozzetto B; Roblin X
Inflamm Bowel Dis; 2015 Jul; 21(7):1580-6. PubMed ID: 25933392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
